DOI: 10.2337/db06-0577 © 2006 by the American Diabetes Association Effects of Sex and Hormone Replacement Therapy Use on the Prevalence of Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance in Subjects With a Family History of Type 2 Diabetes
1 Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington Address correspondence and reprint requests to Kristina Utzschneider, MD, VA Puget Sound Health Care System (151), 1660 S. Columbian Way, Seattle, WA 98108. E-mail: kutzschn{at}u.washington.edu
Abbreviations:
FPG, fasting plasma glucose; GENNID, Genetics of Type 2 Diabetes; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; HRT, hormone replacement therapy; NGT, normal glucose tolerance; OGTT, oral glucose tolerance test
Impaired fasting glucose (IFG) is more prevalent in men and impaired glucose tolerance (IGT) more prevalent in women. To explore whether this sex difference is related to female sex hormones, we performed a cross-sectional analysis of data from 2,164 (1,329 women and 835 men) first-degree relatives of individuals with type 2 diabetes. Subjects were categorized based on a 75-g oral glucose tolerance test. Sex and hormone replacement therapy (HRT) effects on the distribution of glucose tolerance were assessed using multinomial logistic regression corrected for familial clustering. Compared with men, women were more likely to have isolated IGT (relative risk 1.8 [95% CI 1.3–2.5]) and less likely to have isolated IFG (0.5 [0.3–0.7]) adjusted for ethnicity, age, waist, fasting insulin, and early insulin release (
|
|
|
||||||||||||||||||||||||||